A single injection of neuropeptide S into the amygdala one hour after traumatic stress completely abolished extreme anxiety behavior in rats and restored brain BDNF and NPY-Y1 receptor levels, suggesting NPS could be a potential early-intervention treatment for PTSD.
Complete behavioral protectionA single NPS injection into the amygdala 1 hour after trauma completely abolished the extreme anxiety response — one of the strongest effects seen in preclinical PTSD research
What the researchers found
Microinfusion of NPS into the basolateral amygdala (BLA) one hour after predator-scent stress exposure completely abolished the extreme behavioral response in a rat PTSD model. This single treatment restored decreased hippocampal expression of BDNF and, unexpectedly, NPY-Y1 receptor (NPY-Y1R) — though it did not affect decreased NPY expression itself.
Critically, administering both an NPY-Y1R antagonist and an NPS receptor antagonist together had an additive effect that completely prevented NPS's anxiolytic effects and disrupted NPY-Y1R expression. This reveals that NPS acts through both its own receptor and the NPY-Y1R system, and that crosstalk between these two neuropeptide pathways is necessary for the stress-protective effect.
Why it matters
PTSD affects millions of people and current treatments often fall short. This study identifies neuropeptide S as a potential early-intervention target — a single dose given shortly after trauma could prevent PTSD from developing. The unexpected discovery that NPS works through the NPY system creates a mechanistic bridge between two major anxiety-regulating peptide pathways, potentially opening dual-target therapeutic strategies.
How the study worked
Rats were exposed to predator-scent stress (PSS) as a PTSD model, then received microinjections of NPS into the basolateral amygdala 1 hour post-exposure. Behavioral testing assessed anxiety responses long-term. Molecular analyses measured hippocampal expression of NPY, NPY-Y1R, and BDNF. Receptor antagonist experiments (NPS-RA and NPY-Y1RA, alone and combined) dissected the mechanism. Circulating corticosterone was measured at multiple time points.
What this study cannot tell us
The study was conducted in male rats using a predator-scent stress model, which may not fully capture human PTSD. Direct brain microinjection is not a feasible delivery method in humans. The long-term durability of the protective effect was not fully characterized. Female rats were not included, despite known sex differences in PTSD prevalence and neuropeptide biology.
How to read the evidence
This is a preclinical study using a well-established rat PTSD model with rigorous mechanistic dissection using receptor antagonists. The behavioral results are striking but remain in animals only, with no human data yet.
When this study was published
Published in 2018, this study remains highly cited in the neuropeptide S literature and continues to inform research on peptide-based PTSD interventions.
The bigger picture
This study connects two major neuropeptide systems — NPS and NPY — in the context of trauma response, a connection not previously appreciated. It supports the growing concept that the brain's peptide systems don't work in isolation but form interconnected networks that regulate stress resilience. The finding that a brief, early intervention can prevent long-term behavioral pathology aligns with the clinical goal of developing 'golden hour' treatments for PTSD.
Questions still open
- Could intranasal or systemic NPS delivery achieve similar protective effects, making it practical for human use as a post-trauma intervention?
- Does this NPS-NPY crosstalk mechanism operate in humans, and could dual-target drugs be developed?
- Would NPS treatment also work if given at later time points after trauma, or is the one-hour window critical?
Common questions
What is neuropeptide S and could it become a PTSD treatment?
Why is the connection between NPS and NPY important?
Read the original research
Neuropeptide S in the basolateral amygdala mediates an adaptive behavioral stress response in a rat model of posttraumatic stress disorder by increasing the expression of BDNF and the neuropeptide YY1 receptor.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 28(1), 159-170
Citation
Cohen, Hagit; Vainer, Ella; Zeev, Kaplan; Zohar, Joseph; Mathé, Aleksander A. (2018). Neuropeptide S in the basolateral amygdala mediates an adaptive behavioral stress response in a rat model of posttraumatic stress disorder by increasing the expression of BDNF and the neuropeptide YY1 receptor.. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 28(1), 159-170. https://doi.org/10.1016/j.euroneuro.2017.11.006